阿伐麦布
2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)acetyl)sulfamate;N-(2,6-Dipropan-2-ylphenoxy)sulfonyl-2-(2,4,6-tripropan-2-ylphenyl)acetamide;Avasimibe;[[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid;2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)-acetyl)sulfamate;AVASIMIBE(CI-1011);[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate;CI1011;CI-1011;PD148515;PD-148515;Avasimibe Solution, 100ppm;2,6-diisopropylphenyl 2-(2,4,6-triisopropylphenyl)acetylsulfamate;N-[(2,6-DIISOPROPYLPHENOXY)SULFONYL]-2-(2,4,6-TRIISOPROPYLPHENYL)ACETAMIDE;((2,4,6-TRIS(1-METHYLETHYL)PHENYL)ACETYL)SULFAMICACID2,6-BIS(1-METHYLETHYL)PHENYLESTER;CI-1011; PD 148515; [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid;Avasimibe, >=98%;CI 1011;PD 148515;28LQ20T5RC;2,6-Diisopropylphenyl ((2,4,6-triisopropylphenyl)acetyl)sulfamate;((2,4,6-Tris(1-methylethyl)phenyl)acetyl)sulfamic acid 2,6-bis(1-methylethyl)phenyl ester;N;avasimibe;Avasimibe(CI-1011);n-(2,6-dipropan-2-ylphenoxy)sulfonyl-2-(2,4,6-tripropan-2-ylphenyl)acetamide;s2187;SB19572;BCP9000344;DTXSID80168117;AVASIMIBE [INN];Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester;SMR002530075;CHEBI:177719;BCP02302;AVASIMIBE [WHO-DD];DB06442;1-({[2,6-bis(propan-2-yl)phenoxy]sulfonyl}amino)-2-[2,4,6-tris(propan-2-yl)phenyl]ethan-1-one;FT-0737704;Avasimibe,CI-1011;166518-60-1;Avasimibe, >=98% (HPLC);NCGC00346572-01;NCGC00346572-02;C73212;HY-13215;J-523295;Q27254327;BDBM50069900;N-((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)-benzeneacetamide;2,6-bis(1-methylethyl)phenyl ((2,4,6-tris(1-methylethyl)phenyl)acetyl)sulfamate;N-((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)benzeneacetamide;SR-01000944953;SW219628-1;SCHEMBL15876;UNII-28LQ20T5RC;CS-5695;EX-A2230;AKOS015913985;HMS3866C13;Avasimibe (CI-1011)?;MLS006010991;CHEMBL101309;D03012;Avasimibe [USAN:INN];AVASIMIBE [MI];Avasimibe (USAN/INN);CCG-269706;MFCD00934956;Avasimibe (CI-1011);[2-(2,4,6-Triisopropyl-phenyl)-acetyl]-sulfamic acid 2,6-diisopropyl-phenyl ester;BIDD:PXR0029;Benzeneacetamide, N-((2,6-bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)-;MLS006010422;AC-35841;HMS3655H08;NS00068604;Avasimibe [USAN];SR-01000944953-1;[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulamate;AS-74646;Avasimibe; CI-1011; PD-148515